Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| Yesterday 4:01 PM View:  | Protagonist Therapeutics, Inc (PTGX) | 19-Nov-24 | Gift | 1,000 | -- | -- | (< 1%) 514.41K to 513.41K | |
| 17-Jun-24 4:30 PM View: | Protagonist Therapeutics, Inc (PTGX) | 13-Jun-24 | Gift | 1,000 | -- | -- | (< 1%) 515.41K to 514.41K | |
| 11-Jun-24 4:30 PM View: | Protagonist Therapeutics, Inc (PTGX) | 07-Jun-24 | Market Sale (Planned) | 35,000 | $35.19 | $1,231,650.00 | (6%) 550.41K to 515.41K | 2% |
| 02-Apr-24 8:29 PM View: | Protagonist Therapeutics, Inc (PTGX) | 01-Apr-24 | Sale (Planned) | 25,000 | $28.31 | $707,750.00 | (4%) 574.59K to 549.59K | |
| 01-Mar-24 8:46 PM View: | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-24 | Market Sale (Planned) | 30,000 | $31.62 | $948,600.00 | (5%) 604.59K to 574.59K | (9%) |
| 28-Feb-24 8:02 PM View: | Protagonist Therapeutics, Inc (PTGX) | 26-Feb-24 | Payment of Exercise | 10,915 | $29.53 | $322,320.00 | (2%) 615.5K to 604.59K | |
| 20-Feb-24 8:00 PM View: | Protagonist Therapeutics, Inc (PTGX) | 15-Feb-24 | Payment of Exercise | 3,717 | $28.23 | $104,931.00 | (< 1%) 619.22K to 615.5K | |
| 04-Jan-24 8:11 PM View: | Protagonist Therapeutics, Inc (PTGX) | 02-Jan-24 | Grant | 84,875 | -- | -- | 16% 534.35K to 619.22K | |
| 15-Dec-23 4:30 PM View: | Protagonist Therapeutics, Inc (PTGX) | 13-Dec-23 | Sale (Planned) | 75,000 | $20.08 | $1,506,000.00 | (12%) 609.35K to 534.35K | |
| 19-Oct-23 4:55 PM View: | Protagonist Therapeutics, Inc (PTGX) | 18-Oct-23 | Option Exercise | 6,000 | $4.21 | $25,260.00 | < 1% 603.35K to 609.35K | |
| 02-Jun-23 7:50 PM View: | Protagonist Therapeutics, Inc (PTGX) | 31-May-23 | Grant | 30,000 | -- | -- | 5% 585.11K to 615.11K | |
| 02-Jun-23 7:50 PM View: | Protagonist Therapeutics, Inc (PTGX) | 31-May-23 | Payment of Exercise | 12,165 | $26.07 | $317,142.00 | (2%) 615.11K to 602.95K | |
| 02-Jun-23 7:50 PM View: | Protagonist Therapeutics, Inc (PTGX) | 22-Feb-23 | Gift | 10,000 | -- | -- | (2%) 593.45K to 583.45K | |
| 18-Jan-23 7:48 PM View: | Protagonist Therapeutics, Inc (PTGX) | 28-Dec-22 | Gift | 3,116 | -- | -- | (< 1%) 601.21K to 598.1K | |
| 24-Aug-22 6:15 PM View: | Protagonist Therapeutics, Inc (PTGX) | 23-Aug-22 | Option Exercise | 20,000 | $4.21 | $84,200.00 | 3% 584.05K to 604.05K | |
| 04-May-22 8:33 PM View: | Protagonist Therapeutics, Inc (PTGX) | 04-May-22 | Option Exercise | 15,742 | $4.21 | $66,273.80 | 3% 568.31K to 584.05K | |
| 18-Jan-23 7:48 PM View: | Protagonist Therapeutics, Inc (PTGX) | 04-May-22 | Gift | 3,000 | -- | -- | (< 1%) 584.05K to 581.05K | |
| 26-Apr-22 9:34 PM View: | Protagonist Therapeutics, Inc (PTGX) | 26-Apr-22 | Option Exercise | 30,000 | $4.21 | $126,300.00 | 6% 538.31K to 568.31K | |
| 14-Apr-22 8:09 PM View: | Protagonist Therapeutics, Inc (PTGX) | 14-Apr-22 | Option Exercise | 34,087 | $1.89 | $64,424.40 | 7% 503.76K to 537.85K | |
| 02-Mar-22 8:39 PM View: | Protagonist Therapeutics, Inc (PTGX) | 28-Feb-22 | Payment of Exercise | 4,648 | $24.28 | $112,853.00 | (< 1%) 508.41K to 503.76K | |
| 17-Feb-22 7:23 PM View: | Protagonist Therapeutics, Inc (PTGX) | 15-Feb-22 | Grant | 31,250 | -- | -- | 7% 477.16K to 508.41K | |
| 23-Dec-21 4:17 PM View: | Protagonist Therapeutics, Inc (PTGX) | 21-Dec-21 | Market Sale | 15,000 | $32.14 | $482,170.00 | (3%) 492.16K to 477.16K | (2%) |
| 21-Sep-21 10:00 PM View: | Protagonist Therapeutics, Inc (PTGX) | 21-Sep-21 | Option Exercise | 40,000 | $4.21 | $168,400.00 | 9% 452.16K to 492.16K | |
| 26-Feb-21 6:33 PM View: | Protagonist Therapeutics, Inc (PTGX) | 26-Feb-21 | Grant | 25,000 | -- | -- | 6% 426.14K to 451.14K | |
| 20-Jan-21 8:20 PM View: | Protagonist Therapeutics, Inc (PTGX) | 19-Jan-21 | Option Exercise | 13,000 | $4.21 | $54,730.00 | 3% 437.99K to 450.99K | |
| 20-Jan-21 8:20 PM View: | Protagonist Therapeutics, Inc (PTGX) | 19-Jan-21 | Market Option Sale (Planned) | 13,000 | $24.60 | $319,744.00 | (3%) 450.99K to 437.99K | |
| 20-Jan-21 8:20 PM View: | Protagonist Therapeutics, Inc (PTGX) | 19-Jan-21 | Market Sale (Planned) | 11,846 | $24.60 | $291,361.00 | (3%) 437.99K to 426.14K | |
| 01-May-20 5:32 PM View: | Protagonist Therapeutics, Inc (PTGX) | 29-Apr-20 | Gift | 2,000 | -- | -- | (< 1%) 439.99K to 437.99K | |
| 23-Mar-20 6:14 PM View: | Protagonist Therapeutics, Inc (PTGX) | 20-Mar-20 | Option Exercise | 10,000 | $1.89 | $18,900.00 | 2% 429.99K to 439.99K | |
| 13-Mar-20 1:04 PM View: | Protagonist Therapeutics, Inc (PTGX) | 12-Mar-20 | Option Exercise | 18,344 | $1.16 | $21,279.00 | 4% 411.65K to 429.99K | |
| 03-Dec-19 6:10 PM View: | Protagonist Therapeutics, Inc (PTGX) | 03-Dec-19 | Market Purchase | 30,000 | $5.62 | $168,500.00 | 8% 379.82K to 409.82K | 323% |
| 27-Nov-19 2:58 PM View: | Protagonist Therapeutics, Inc (PTGX) | 26-Nov-19 | Option Exercise | 4,000 | $1.16 | $4,640.00 | 1% 375.82K to 379.82K | |
| 08-Aug-19 6:15 PM View: | Protagonist Therapeutics, Inc (PTGX) | 06-Aug-19 | Market Sale | 10,792 | $8.85 | $95,535.10 | (3%) 385.58K to 374.79K | (168%) |
| 04-Mar-19 6:33 PM View: | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-19 | Market Sale | 2,183 | $8.03 | $17,529.50 | (< 1%) 386.01K to 383.83K | (196%) |
| 04-Mar-19 6:33 PM View: | Protagonist Therapeutics, Inc (PTGX) | 28-Feb-19 | Grant | 28,750 | -- | -- | 8% 357.26K to 386.01K | |
| 08-Feb-19 5:37 PM View: | Protagonist Therapeutics, Inc (PTGX) | 06-Feb-19 | Market Sale | 10,909 | $7.74 | $84,409.90 | (3%) 368.17K to 357.26K | (207%) |
| 14-Jan-19 7:00 PM View: | Protagonist Therapeutics, Inc (PTGX) | 11-Jan-19 | Option Exercise | 22,344 | $1.16 | $25,919.00 | 6% 345.83K to 368.17K | |
| 17-Aug-18 8:25 PM View: | Protagonist Therapeutics, Inc (PTGX) | 15-Aug-18 | Grant | 82,050 | -- | -- | 31% 263.78K to 345.83K | |
| 13-Jul-18 6:36 PM View: | Protagonist Therapeutics, Inc (PTGX) | 12-Jul-18 | Gift | 2,000 | -- | -- | (< 1%) 265.78K to 263.78K | |
| 11-May-18 6:50 PM View: | Protagonist Therapeutics, Inc (PTGX) | 10-May-18 | Option Exercise | 13,516 | $1.16 | $15,678.60 | 5% 252.26K to 265.78K | |
| 03-Apr-18 5:17 PM View: | Protagonist Therapeutics, Inc (PTGX) | 02-Apr-18 | Option Exercise | 20,000 | $1.16 | $23,200.00 | 9% 232.26K to 252.26K | |
| 28-Mar-18 5:20 PM View: | Protagonist Therapeutics, Inc (PTGX) | 26-Mar-18 | Option Exercise | 11,298 | $0.87 | $9,829.26 | 5% 220.97K to 232.26K | |
| 02-Mar-18 7:23 PM View: | Protagonist Therapeutics, Inc (PTGX) | 28-Feb-18 | Grant | 25,000 | -- | -- | 13% 194.26K to 219.26K | |
| 21-Dec-17 7:54 PM View: | Protagonist Therapeutics, Inc (PTGX) | 21-Dec-17 | Option Exercise | 8,210 | $1.89 | $15,516.90 | 4% 190.44K to 198.65K | |
| 21-Dec-17 7:54 PM View: | Protagonist Therapeutics, Inc (PTGX) | 21-Dec-17 | Market Option Sale (Planned) | 8,210 | $19.56 | $160,570.00 | (4%) 198.65K to 190.44K | (21%) |
| 20-Dec-17 9:28 PM View: | Protagonist Therapeutics, Inc (PTGX) | 20-Dec-17 | Option Exercise | 1,790 | $1.89 | $3,383.10 | < 1% 190.44K to 192.23K | |
| 20-Dec-17 9:28 PM View: | Protagonist Therapeutics, Inc (PTGX) | 20-Dec-17 | Market Option Sale (Planned) | 1,790 | $19.55 | $34,987.30 | (< 1%) 192.23K to 190.44K | (22%) |
| 10-May-17 8:44 PM View: | Protagonist Therapeutics, Inc (PTGX) | 09-May-17 | Option Exercise | 19,099 | $1.16 | $22,154.80 | 11% 171.34K to 190.44K | |
| 07-Apr-17 9:24 PM View: | Protagonist Therapeutics, Inc (PTGX) | 06-Apr-17 | Option Exercise | 20,000 | $1.16 | $23,200.00 | 13% 151.34K to 171.34K | |
| 13-Mar-17 7:24 PM View: | Protagonist Therapeutics, Inc (PTGX) | 10-Mar-17 | Option Exercise | 16,362 | $0.87 | $14,234.90 | 12% 134.98K to 151.34K |